Favorable outcome of chronic myeloid leukemia co-expressing e13a2 and e14a2 transcripts, treated with nilotinib
- PMID: 32602167
- DOI: 10.1002/hon.2765
Favorable outcome of chronic myeloid leukemia co-expressing e13a2 and e14a2 transcripts, treated with nilotinib
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
